Preventive Medication Use among Adults Aged 40 and over in the United States: National Health and Nutrition Examination Survey, 2015–2018
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Sample
2.2. Measurements
2.2.1. Outcome
2.2.2. Explanatory Variables
2.3. Missing Data
2.4. Statistical Techniques
3. Results
3.1. Description of the Study Sample
3.2. Explanatory Variables and Preventive Prescription Medications Use
3.3. Preventive Prescription Medications
3.4. Primary Reasons for Using Preventive Prescription Medications
4. Discussion
5. Conclusions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Gu, Q.; Paulose-Ram, R.; Burt, V.L.; Kit, B.K. Prescription Cholesterol Lowering Medication Use in Adults Aged 40 and Over: United States, 2003–2012; National Center for Health Statistics: Hyattsville, MD, USA, 2014.
- Wang, K.; Li, Y.; Liu, G.; Rimm, E.; Chan, A.T.; Giovannucci, E.L.; Song, M. Healthy Lifestyle for Prevention of Premature Death Among Users and Nonusers of Common Preventive Medications: A Prospective Study in 2 US Cohorts. J. Am. Heart Assoc. 2020, 9, e016692. [Google Scholar] [CrossRef] [PubMed]
- Williams, C.D.; Chan, A.T.; Elman, M.R.; Kristensen, A.H.; Miser, W.F.; Pignone, M.P.; Stafford, R.S.; McGregor, J.C. Aspirin use among adults in the US: Results of a national survey. Am. J. Prev. Med. 2015, 48, 501–508. [Google Scholar] [CrossRef] [PubMed]
- Gu, Q.; Dillon, C.F.; Eberhardt, M.S.; Wright, J.D.; Burt, V.L. Preventive aspirin and other antiplatelet medication use among US adults aged ≥ 40 years: Data from the National Health and Nutrition Examination Survey, 2011–2012. Public Health Rep. 2015, 130, 643–654. [Google Scholar] [CrossRef] [PubMed]
- Owens, D.K.; Davidson, K.W.; Krist, A.H.; Barry, M.J.; Cabana, M.; Caughey, A.B.; Doubeni, C.A.; Epling, J.W., Jr.; Kubik, M.; Landefeld, S.C.; et al. Medication use to reduce risk of breast cancer: US Preventive Services Task Force recommendation statement. JAMA 2019, 322, 857–867. [Google Scholar] [PubMed]
- D’Amico, D.; Tepper, S.J. Prophylaxis of migraine: General principles and patient acceptance. Neuropsychiatr. Dis. Treat. 2008, 4, 1155. [Google Scholar] [CrossRef] [PubMed]
- McCombs, J.S.; Thiebaud, P.; McLaughlin-Miley, C.; Shi, J. Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004, 48, 271–287. [Google Scholar] [CrossRef] [PubMed]
- Padwal, R.; Majumdar, S.R.; Johnson, J.A.; Varney, J.; McAlister, F.A. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care 2005, 28, 736–744. [Google Scholar] [CrossRef]
- Kroenke, K.; Spitzer, R.L.; Williams, J.B. The PHQ-9: Validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef]
- Archer, K.J.; Lemeshow, S. Goodness-of-fit test for a logistic regression model fitted using survey sample data. Stata J. 2006, 6, 97–105. [Google Scholar] [CrossRef]
- Tolbert, J.; Orgera, K.; Damico, A. Key Facts about the Uninsured Population. Henry J Kaiser Family Foundation. 2020. Available online: https://www.kff.org/uninsured/issue-brief/key-facts-about-the-uninsured-population/ (accessed on 5 February 2022).
- Ito, K.; Avorn, J.; Shrank, W.H.; Toscano, M.; Spettel, C.; Brennan, T.; Choudhry, N.K. Long-term cost-effectiveness of providing full coverage for preventive medications after myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 2015, 8, 252–259. [Google Scholar] [CrossRef] [PubMed]
- Rhee, T.G.; Kumar, M.; Ross, J.S.; Coll, P.P. Age-related trajectories of cardiovascular risk and use of aspirin and statin among US adults aged 50 or older, 2011–2018. J. Am. Geriatr. Soc. 2021, 69, 1272–1282. [Google Scholar] [CrossRef] [PubMed]
- Guirguis-Blake, J.M.; Evans, C.V.; Perdue, L.A.; Bean, S.I.; Senger, C.A. Aspirin use to prevent cardiovascular disease and colorectal cancer: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 2022, 327, 1585–1597. [Google Scholar] [CrossRef] [PubMed]
- Van Middelaar, T.; van Charante, E.P.M. Deprescribing preventive medication in older patients. Br. J. Gen. Pract. 2018, 68, 456–457. [Google Scholar] [CrossRef] [PubMed]
- Liu, E.Y.; Al-Sofiani, M.E.; Yeh, H.-C.; Echouffo-Tcheugui, J.B.; Joseph, J.J.; Kalyani, R.R. Use of preventive aspirin among older us adults with and without diabetes. JAMA Open 2021, 4, e2112210. [Google Scholar] [CrossRef] [PubMed]
- Murchison, A.P.; Hark, L.; Pizzi, L.T.; Dai, Y.; Mayro, E.L.; Storey, P.P.; Leiby, B.E.; Haller, J.A. Non-adherence to eye care in people with diabetes. BMJ Open Diabetes Res. Care 2017, 5, e000333. [Google Scholar] [CrossRef] [PubMed]
- Centers for Disease Control and Prevention. Prevalence of receiving multiple preventive-care services among adults with diabetes—United States, 2002–2004. MMWR. Morb. Mortal. Wkly. Rep. 2005, 54, 1130–1133. [Google Scholar]
- Meraya, A.M.; Makeen, H.A. Self-reported receipt of preventive practices and its associated factors among adults with diabetes in the United States. Prev. Med. Rep. 2019, 14, 100857. [Google Scholar] [CrossRef] [PubMed]
Aspirin Use and/or Other Preventive Medications | Aspirin Use Only | Other Preventive Medications | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
All | No | Yes | p-Value | No | Yes | p-Value | No | Yes | p-Value | ||
ALL | 69 | 31 | 73 | 27 | 91 | 9 | |||||
Sex | <0.001 | <0.001 | 0.021 | ||||||||
Female | 53 | 54.8 | 48.3 | 54.9 | 47.2 | 53.5 | 46.1 | ||||
Male | 47 | 45.2 | 51.7 | 45.1 | 52.8 | 46.5 | 53.9 | ||||
Age groups | <0.001 | <0.001 | <0.001 | ||||||||
40–49 | 26 | 34.4 | 7.8 | 33.3 | 7 | 27.9 | 9.6 | ||||
50–64 | 42 | 44.2 | 36.3 | 43.6 | 36.7 | 42.6 | 33 | ||||
65–74 | 19 | 14.4 | 29.8 | 14.9 | 30.7 | 18.2 | 28.9 | ||||
≥75 | 13 | 7 | 26 | 8.2 | 25.6 | 11.4 | 28.5 | ||||
Race | <0.001 | <0.001 | 0.034 | ||||||||
Mexican American | 7 | 7.7 | 5.3 | 7.6 | 5.2 | 7.1 | 5.9 | ||||
Other Hispanic | 6 | 6 | 4.6 | 6 | 4.3 | 5.6 | 5.3 | ||||
Non-Hispanic White | 68 | 65.9 | 71.4 | 66 | 71.9 | 67.1 | 72.3 | ||||
Non-Hispanic Black | 11 | 10.7 | 10.2 | 10.7 | 10.1 | 10.7 | 8.6 | ||||
Other Race | 9 | 9.7 | 8.6 | 9.7 | 8.5 | 9.5 | 8 | ||||
Marital Status | <0.001 | <0.001 | 0.010 | ||||||||
Married | 62 | 62.8 | 61.2 | 62.5 | 61.9 | 62.3 | 63.3 | ||||
Widowed | 9 | 7 | 13.7 | 7.4 | 13.5 | 8.6 | 14.1 | ||||
Divorced | 14 | 14.3 | 12.3 | 14.3 | 12.1 | 14 | 10.6 | ||||
Separated | 3 | 2.7 | 2.6 | 2.7 | 2.6 | 2.7 | 2.4 | ||||
Never Married | 7 | 7.3 | 6.3 | 7.4 | 6 | 7 | 6.8 | ||||
Living with Partner | 5 | 5.9 | 3.9 | 5.8 | 3.9 | 5.5 | 2.7 | ||||
Education | 0.042 | 0.064 | 0.165 | ||||||||
<High School | 13 | 13.2 | 14.1 | 13.5 | 13.3 | 13.2 | 15.9 | ||||
High School | 24 | 22.8 | 25.9 | 22.7 | 26.7 | 23.9 | 22.3 | ||||
Some College | 31 | 30.6 | 31.3 | 31 | 30.4 | 30.5 | 34 | ||||
College + | 32 | 33.4 | 28.6 | 32.8 | 29.6 | 32.3 | 27.8 | ||||
Poverty status | 0.367 | 0.224 | 0.830 | ||||||||
Poor | 11 | 11.9 | 10.6 | 12 | 9.9 | 11.4 | 12.3 | ||||
Near-Poor | 18 | 17.9 | 19.9 | 17.9 | 20.1 | 18.4 | 19 | ||||
Middle Income | 15 | 14.8 | 15.2 | 15 | 14.7 | 14.9 | 15.4 | ||||
High Income | 55 | 55.5 | 54.4 | 55.1 | 55.3 | 55.3 | 53.2 | ||||
Health insurance | <0.001 | <0.001 | <0.001 | ||||||||
Private Only | 45 | 52.8 | 27.9 | 51.3 | 28.1 | 47 | 25.3 | ||||
Public Only | 21 | 17.1 | 30.3 | 18 | 29.6 | 19.9 | 34 | ||||
Public and Private | 17.2 | 11.1 | 30.9 | 12.2 | 30.9 | 15.7 | 32.7 | ||||
Other | 7.5 | 7.9 | 6.6 | 7.7 | 6.8 | 7.8 | 4.3 | ||||
Uninsured | 9 | 11.2 | 4.3 | 10.8 | 4.5 | 9.6 | 3.6 | ||||
Diabetes | <0.001 | <0.001 | <0.001 | ||||||||
No | 84 | 90.9 | 67.3 | 89.4 | 67.8 | 85.8 | 61.5 | ||||
Yes | 16 | 9.1 | 32.7 | 10.6 | 32.2 | 14.2 | 38.5 | ||||
Arthritis | <0.001 | <0.001 | <0.001 | ||||||||
No | 61 | 67.4 | 45.3 | 66 | 46.1 | 62.5 | 41.3 | ||||
Yes | 39 | 32.6 | 54.7 | 34 | 53.9 | 37.5 | 58.7 | ||||
Hypertension | <0.001 | <0.001 | <0.001 | ||||||||
No | 56 | 67 | 32.7 | 65.1 | 32.6 | 58.9 | 30.9 | ||||
Yes | 44 | 33 | 67.3 | 34.9 | 67.4 | 41.1 | 69.1 | ||||
Heart Disease | <0.001 | <0.001 | <0.001 | ||||||||
No | 86 | 95.2 | 66.4 | 93.7 | 66.3 | 89.3 | 55.3 | ||||
Yes | 14 | 4.8 | 33.6 | 6.3 | 33.7 | 10.7 | 44.7 | ||||
Other Chronic Physical Conditions | <0.001 | <0.001 | <0.001 | ||||||||
None | 59 | 64 | 46.7 | 62.7 | 47.8 | 60.3 | 41.7 | ||||
≥1 | 41 | 36 | 53.3 | 37.3 | 52.2 | 39.7 | 58.3 | ||||
Depression | 0.012 | 0.128 | 0.005 | ||||||||
No | 92 | 92.9 | 90.6 | 92.6 | 91.1 | 92.6 | 87.7 | ||||
Yes | 8 | 7.1 | 9.4 | 7.4 | 8.9 | 7.4 | 12.3 | ||||
Smoking Status | <0.001 | <0.001 | 0.052 | ||||||||
Never Smoker | 54 | 55.8 | 50.2 | 55.7 | 49.7 | 54.2 | 53.2 | ||||
Currently Smoker | 16 | 17.5 | 12.4 | 17 | 12.8 | 16.3 | 11.8 | ||||
Past Smoker | 30 | 26.7 | 37.4 | 27.3 | 37.5 | 29.5 | 35 |
AOR | 95% CI | p-Value | ||
---|---|---|---|---|
Sex | ||||
Male | Reference (1) | |||
Female | 0.746 | (0.628–0.885) | 0.001 | |
Age Groups | ||||
40–49 | Reference (1) | |||
50–64 | 2.616 | (1.947–3.514) | <0.001 | |
65–74 | 4.271 | (2.869–6.358) | <0.001 | |
≥75 | 6.985 | (4.632–10.532) | <0.001 | |
Race–Ethnicity | ||||
Non-Hispanic White | Reference (1) | |||
Mexican Americans | 0.995 | (0.777–1.274) | 0.966 | |
Other Hispanic | 0.882 | (0.65–1.197) | 0.408 | |
Non-Hispanic Black | 0.918 | (0.747–1.127) | 0.4 | |
Other Race | 0.843 | (0.678–1.048) | 0.12 | |
Marital Status | ||||
Married | Reference (1) | |||
Widowed | 0.648 | (0.484–0.868) | 0.005 | |
Divorced | 0.771 | (0.585–1.015) | 0.063 | |
Separated | 1.131 | (0.63–2.029) | 0.671 | |
Never Married | 1.083 | (0.612–1.919) | 0.777 | |
Living with Partner | 0.674 | (0.494–0.92) | 0.015 | |
Health Insurance | ||||
Private Only | Reference (1) | |||
Public Only | 1.075 | (0.846–1.365) | 0.542 | |
Public and Private | 1.393 | (0.946–2.052) | 0.091 | |
Other | 1.182 | (0.906–1.543) | 0.21 | |
Uninsured | 0.656 | (0.483–0.892) | 0.009 | |
Smoking Status | ||||
Currently Smoker | Reference (1) | |||
Past Smoker | 1.431 | (1.065–1.922) | 0.019 | |
Never Smoker | 1.423 | (1.053–1.922) | 0.023 | |
Diabetes | ||||
No | Reference (1) | |||
Yes | 2.779 | (2.097–3.684) | <0.001 | |
Arthritis | ||||
No | Reference (1) | |||
Yes | 1.344 | (1.052–1.717) | 0.020 | |
Hypertension | ||||
No | Reference (1) | |||
Yes | 2.294 | (1.931–2.726) | <0.001 | |
Heart Disease | ||||
No | Reference (1) | |||
Yes | 5.504 | (4.388–6.905) | <0.001 | |
Other Chronic Physical Conditions | ||||
None | Reference (1) | |||
≥1 | 1.188 | (0.988–1.429) | 0.067 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Meraya, A.M. Preventive Medication Use among Adults Aged 40 and over in the United States: National Health and Nutrition Examination Survey, 2015–2018. Healthcare 2022, 10, 1875. https://doi.org/10.3390/healthcare10101875
Meraya AM. Preventive Medication Use among Adults Aged 40 and over in the United States: National Health and Nutrition Examination Survey, 2015–2018. Healthcare. 2022; 10(10):1875. https://doi.org/10.3390/healthcare10101875
Chicago/Turabian StyleMeraya, Abdulkarim M. 2022. "Preventive Medication Use among Adults Aged 40 and over in the United States: National Health and Nutrition Examination Survey, 2015–2018" Healthcare 10, no. 10: 1875. https://doi.org/10.3390/healthcare10101875